{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:57:06Z","timestamp":1791593826067,"version":"4.3.4"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.81673910"],"award-info":[{"award-number":["No.81673910"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Guillain-Barre syndrome (GBS) is a disease with the features of acuteness, paralysis, inflammation, and in peripheral nerves. There are many current treatment options with varying efficacy, and to assess their effectiveness, we performed a network meta-analysis (NMA). The study protocol was registered at PROSPERO (CRD: 42019119178). Posted history: this manuscript was previously posted to medRxiv: doi: https:\/\/doi.org\/10.1101\/2020.06.03.20121780.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The literature search database includes Web of Science, PubMed, Embase, and the Cochrane library that meets the requirements. We performed the NMA using controlled trials with 2 kinds of outcomes. We used the gemtc R package to perform the NMA to evaluate different GBS treatments\u2019 relative results. The consistency of direct and indirect evidence was also assessed by R software with gemtc package.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>This NMA study included a total of 2474 subjects from 28 trials with 15 kinds of therapies. No improvement was observed in methylprednisolone and prednisolone compared with placebo. Conversely, plasma exchange (PE) and intravenous immunoglobulin (IVIg) were more effective than placebo. There was no significant difference between different doses and courses of PE and IVIg. For combination treatment, such as IVIg+eculizumab, immunoadsorption followed by IVIg and PE followed by IVIg, they didn\u2019t show significant advantages than IVIg and PE in NMA. On the consistency examination between direct and indirect evidence, there was no apparent heterogeneity between them. Funnel plots indicated there was little possibility of publication bias in this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>PE or IVIg has significant efficacy for GBS patients. The effects of several kinds of therapies should be further explored. Corticosteroids have no considerable impact on GBS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000027351","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T17:26:16Z","timestamp":1637688376000},"page":"e27351","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":27,"title":["Efficacy of therapies in the treatment of Guillain-Barre syndrome"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6307-1864","authenticated-orcid":false,"given":"Jingfeng","family":"Lin","sequence":"first","affiliation":[{"name":"Hangzhou Seventh People's Hospital, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Gao","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Xiao","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Tian","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyue","family":"Hu","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyun","family":"Han","sequence":"additional","affiliation":[{"name":"Shenzhen Hospital of Beijing University of Chinese Medicine (Longgang), Shenzhen, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10072-015-2450-4","article-title":"Looks can be deceiving: three cases of neurological diseases mimicking Guillain\u2013Barr\u00e8 syndrome","volume":"37","author":"Sciacca","year":"2016","journal-title":"Neurol Sci"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1212\/01.WNL.0000055091.96905.D0","article-title":"Guillain-Barr\u00e9 syndrome: a prospective, population-based incidence and outcome survey","volume":"60","author":"Chi\u00f2","year":"2003","journal-title":"Neurology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jnnp.64.1.74","article-title":"Epidemiological study of Guillain-Barre syndrome in south east England","volume":"64","author":"Rees","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMc1208413","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"367","author":"Paterson","year":"2012","journal-title":"N Engl J Med"},{"key":"R5-20250504","first-page":"CD001798","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","author":"Rapha\u00ebl","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20250504","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-20250504","first-page":"CD001446","article-title":"Corticosteroids for Guillain-Barr\u00e9 syndrome","author":"Hughes","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20250504","first-page":"CD008630","article-title":"Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barr\u00e9 syndrome","author":"Hughes","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"e115065","DOI":"10.1371\/journal.pone.0115065","article-title":"Network meta-analysis using r: a review of currently available automated packages","volume":"9","author":"Neupane","year":"2014","journal-title":"PLoS ONE"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.46.1.100","article-title":"Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barre syndrome","volume":"46","author":"Bril","year":"1996","journal-title":"Neurology"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"08","DOI":"10.1542\/peds.2004-1324","article-title":"Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barre syndrome: a randomized trial","volume":"116","author":"Korinthenberg","year":"2005","journal-title":"Pediatrics"},{"key":"R12-20250504","first-page":"69","article-title":"A randomized controlled trial comparing intravenous immunoglobulin and plasmapheresis in Guillain-Barr\u00e9 syndrome","volume":"18","author":"Nomura","year":"2001","journal-title":"Neurol Ther"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome","volume":"349","author":"Hughes","year":"1997","journal-title":"Lancet"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/jnnp.71.2.235","article-title":"Intravenous immune globulins in patients with Guillain-Barr\u00e9 syndrome and contraindications to plasma exchange: 3\u200adays versus 6\u200adays","volume":"71","author":"Raphael","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R15-20250504","first-page":"329","article-title":"Role of steroids in the treatment of Guillain-Barr\u00e9 syndrome-a controlled trial","volume":"34","author":"Bansal","year":"1986","journal-title":"Neurol India"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1212\/WNL.57.5.774","article-title":"CSF filtration is an effective treatment of Guillain-Barre syndrome: a randomized clinical trial","volume":"57","author":"Wollinsky","year":"2001","journal-title":"Neurology"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcms.2010.11.001","article-title":"Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias","volume":"39","author":"Knobloch","year":"2010","journal-title":"J Craniomaxillofac Surg"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jrsm.1054","article-title":"Automating network meta-analysis","volume":"3","author":"van Valkenhoef","year":"2012","journal-title":"Res Synth Methods"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2288-13-35","article-title":"A graphical tool for locating inconsistency in network meta-analyses","volume":"13","author":"Krahn","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","article-title":"Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome: randomised trial","volume":"363","author":"van Koningsveld","year":"2004","journal-title":"Lancet"},{"key":"R21-20250504","first-page":"586","article-title":"Double-blind trial of intravenous methylprednisolone in Guillain-Barre syndrome. Guillain-Barre Syndrome Steroid Trial Group","volume":"341","author":"Steroid","year":"1993","journal-title":"Lancet"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"R23-20250504","first-page":"22","article-title":"Do corticosteroids influence the disease course or mortality in Guillain-Barre'syndrome?","volume":"44","author":"Singh","year":"1996","journal-title":"J Assoc Physicians India"},{"key":"R24-20250504","first-page":"128","article-title":"Double blind control trial of prednisolone in Guillain-Barr\u00e9 syndrome: a clinical study","volume":"52","author":"Shukla","year":"1988","journal-title":"Clin India"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/01.WNL.0000092019.53628.88","article-title":"A randomized controlled trial of recombinant interferon-beta 1a in Guillain-Barr\u00e9 syndrome","volume":"61","author":"Pritchard","year":"2003","journal-title":"Neurology"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1468-1331.2000.00096.x","article-title":"Randomized controlled trial of brain-derived neurotrophic factor in Guillain\u2013Barr\u00e9 syndrome: a pilot study","volume":"7","author":"Bensa","year":"2000","journal-title":"Eur J Neurol"},{"key":"R27-20250504","first-page":"332","article-title":"Effect of Tripterygium polyglycoside on interleukin-6 in patients with Guillain-Barre syndrome","volume":"20","author":"Zhang","year":"2000","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000050777","article-title":"A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barr\u00e9 syndrome","volume":"46","author":"Philipp","year":"2001","journal-title":"Eur Neurol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/cc10305","article-title":"Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barr\u00e9 syndrome: a randomized study","volume":"15","author":"El-Bayoumi","year":"2011","journal-title":"Crit Care"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0022-510X(95)00357-8","article-title":"Sequential treatment of Guillain-Barr\u00e9 syndrome with extracorporeal elimination and intravenous immunoglobulin","volume":"137","author":"Haupt","year":"1996","journal-title":"J Neurol Sci"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome","volume":"326","author":"Van der Mech\u00e9","year":"1992","journal-title":"N Engl J Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0140-6736(84)91341-2","article-title":"Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy","volume":"323","author":"Greenwood","year":"1984","journal-title":"Lancet"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain-Barre syndrome","volume":"35","author":"Gbs","year":"1985","journal-title":"Neurology"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0140-6736(84)90819-5","article-title":"Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy","volume":"324","author":"Osterman","year":"1984","journal-title":"Lancet"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.410220612","article-title":"Efficiency of plasma exchange in Guillain-Barr\u00e9 syndrome: role of replacement fluids","volume":"22","author":"French","year":"1987","journal-title":"Ann Neurol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jca.21646","article-title":"Cost-minimization analysis in the Indian subcontinent for treating Guillain Barre Syndrome patients with therapeutic plasma exchange as compared to intravenous immunoglobulin","volume":"33","author":"Maheshwari","year":"2018","journal-title":"J Clin Apher"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/tme.12169","article-title":"Comparison on therapeutic effect of plasma exchange and intravenous immunoglobulin for Guillian-Barre syndrome","volume":"25","author":"Ye","year":"2015","journal-title":"Transfus Med"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"04","DOI":"10.1111\/jns.12194","article-title":"Inhibition of complement in Guillain-Barr\u00e9 syndrome: the ICA-GBS study","volume":"22","author":"Davidson","year":"2017","journal-title":"J Peripher Nerv Syst"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(18)30114-5","article-title":"Safety and efficacy of eculizumab in Guillain-Barr\u00e9 syndrome: a multicentre, double-blind, randomised phase 2 trial","volume":"17","author":"Misawa","year":"2018","journal-title":"Lancet Neurol"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1167","article-title":"Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis","volume":"7","author":"van Valkenhoef","year":"2016","journal-title":"Res Synth Methods"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1212\/WNL.43.5.1034","article-title":"Human immune globulin infusion in Guillain-Barr\u00e9 syndrome: worsening during and after treatment","volume":"43","author":"Castro","year":"1993","journal-title":"Neurology"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1537-2995.1988.28188127949.x","article-title":"Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura","volume":"28","author":"Bussel","year":"1988","journal-title":"Transfusion"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/jnnp.57.5.578","article-title":"Immunoadsorption therapy for myasthenia gravis","volume":"57","author":"Shibuya","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1212\/WNL.45.2.338","article-title":"Treatment of myasthenia gravis by immunoadsorption of plasma","volume":"45","author":"Grob","year":"1995","journal-title":"Neurology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:39:08Z","timestamp":1746319148000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027351"}},"subtitle":["A network meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":46,"journal-issue":{"issue":"41","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027351","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.03.20121780","asserted-by":"object"}]},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"2020-07-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}